CLS-Logo-1.jpg
CLS Presents Image-Guided Laser Thermotherapy Enhancements at MedTech Investing Europe Conference in London, UK
November 25, 2019 03:00 ET | Clinical Laserthermia Systems Americas, Inc.
LONDON, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its high precision, image-guided TRANBERG® çLaser Thermal Therapy System, new MRI-integrated...
provectus_logo.jpg
PV-10-based Cancer Combination Therapy Clinical Trial Design Wins Australasian Gastro-Intestinal Trials Group’s New Concepts Award
August 27, 2019 09:00 ET | Provectus Biopharmaceuticals Inc.
Two-stage, 34-patient, Phase 2 study combines PV-10 and Keytruda® (pembrolizumab) for treatment of metastatic neuroendocrine tumorsCombination powered for 19% ORR vs 3.7% ORR for Keytruda...
logo (1).jpg
Vaccex, Inc is pleased to announce the formal engagement of Dr. Per Horn as President and Chief Executive Officer
July 09, 2019 09:00 ET | Vaccex Inc
BOSTON, July 09, 2019 (GLOBE NEWSWIRE) -- Vaccex, Inc. (OTC: VCEX), a Boston, Massachusetts-based biotechnology company that is developing immunotherapies for the treatment of cancer, announced...
CLS-Logo-1.jpg
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors ST. LOUIS and IRVINE, Calif., June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS-Logo-1.jpg
Immunophotonics and Clinical Laserthermia Systems Announce Immuno-Oncology Research Collaboration and Clinical Trials for Cancer Patients with Solid Tumors ST. LOUIS and LUND, Sweden, June 14, 2019 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. and Clinical Laserthermia Systems, AB (STO:CLS B) (CLS) today announced they have entered into a research...
CLS-Logo-1.jpg
CLS Presents Image-Guided Laser Immunotherapy System at 16th Annual Anglonordic Life Science Investor Conference
May 07, 2019 07:00 ET | Clinical Laserthermia Systems Americas, Inc.
CEO Will Discuss New Products, Clinical Studies, and Industry Partners LONDON, May 07, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) will present its TRANBERG® çThermal...
CLS-Logo-1.jpg
CLS Releases White Paper Regarding its imILT® Immuno-Stimulating Method for Treating Cancer Tumours at ECIO 2019 Conference
April 08, 2019 03:45 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, April 08, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today released a technical white paper regarding the company’s imILT® immuno-stimulating method for...
CLS-Logo-1.jpg
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
March 25, 2019 03:00 ET | Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical studies and results for its imILT® heat-induced cancer immunotherapy for...
LogoPressRelease.jpg
Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
November 08, 2018 08:30 ET | Fluidigm Corporation
A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation...
LogoPressRelease.jpg
Fluidigm Recognized as a Company to Watch in 2019
November 07, 2018 16:11 ET | Fluidigm Corporation
Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm...